Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Office Of Regulatory Affairs Make-Over Blends Domestic, International Work

This article was originally published in The Gray Sheet

Executive Summary

The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.

You may also be interested in...

People Briefs: Encision, Solta, Chembio, Accuray, Devon and FDA

Encision CEO Fred Perner dead at 59. Solta Medical CEO resigns. Chembio president and CEO announces he will retire in May. FDA gains permanent regulatory affairs chief. More people news.

People In Brief

Former Lutonix chief Dennis Wahr takes helm at Innovative Pulmonary Solutions. FDA gets two new associate commissioners. More people news.

FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts

FDA's Office of Regulatory Affairs still plans to reorganize, despite its recent decision to cancel the planned closure of seven field labs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts